Drug-labels.com

Jamp Solifenacin Succinate: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
5 mg, 10 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Jamp Solifenacin Succinate

ABOUT THIS MEDICATION

T THIS MEDICATION

What the medication is used for:

JAMP Solifenacin Succinate is used in the treatment of overactive bladder in adults with symptoms of frequent and urgent need to urinate (urinary frequency, urinary urgency) with urine leakage (urge urinary incontinence).

What it does:

JAMP Solifenacin Succinate is a urinary antispasmodic medication that helps to relax the smooth muscle of the bladder which leads to reduce the symptoms caused by overactive bladder.

When it should not be used:

You should not take JAMP Solifenacin Succinate:

  • If you are not able to empty your bladder (also called urinary retention).
  • If you have End-Stage Kidney Disease and require dialysis.
  • If you are not able to empty your stomach (also called gastroparesis).
  • If you have narrow-angle glaucoma (high pressure and pain in the eyes).
  • If you are allergic to solifenacin succinate or any of the other ingredients in JAMP Solifenacin Succinate. See ‘What the non-medicinal ingredients are’

What the medicinal ingredient is:

The medicinal ingredient in JAMP Solifenacin Succinate Tablet is ‘solifenacin succinate’.

What the non-medicinal ingredients are:

Each JAMP Solifenacin Succinate tablet contains the following inert ingredients: sodium stearyl fumarate , lactose monohydrate, PVP K30, pregelatinised starch, hypromellose, talc, macrogol, titanium dioxide with iron oxide yellow (5 mg JAMP Solifenacin Succinate) or iron oxide red (10 mg JAMP Solifenacin Succinate).

What dosage form it comes in:

JAMP Solifenacin Succinate is available in 5 and 10 mg tablets.

WARNINGS AND PRECAUTIONS

Before you use JAMP Solifenacin Succinate, talk to your doctor or pharmacist if you:

  • Have stomach problems affecting passage and digestion of food, or severe constipation.
  • Have glaucoma.
  • Have difficulty urinating, or weak urine stream.
  • Have heart disease
  • Have a rare heart problem called QT/QTc prolongation or family history of QT/QTc prolongation.
  • Have kidney or liver problems.
  • Have reduced ability to sweat.
  • Are pregnant or planning to become pregnant. Women who might get pregnant should use an effective birth control method while taking JAMP Solifenacin Succinate.

  • Are breastfeeding or plan to breastfeed.

JAMP Solifenacin Succinate should not be given to children or adolescents.

JAMP Solifenacin Succinate may cause blurred vision and drowsiness. Do not drive a car, operate any machinery, or engage in any activities that require accurate vision and full attention.

In hot weather, JAMP Solifenacin Succinate can cause heat prostration (fever and heat stroke due to decreased sweating). Do not stay long in a hot environment while taking the drug. If you have any symptoms of heat prostration, keep yourself cool and drink a lot of water.

Angioedema (the symptoms include swelling of the face or tongue, difficulty breathing) and anaphylactic reactions (the symptoms include hives, difficulty breathing, abdominal cramps, rapid heartbeat and feeling faint), which could be life- threatening, have been reported in some patients taking solifenacin succinate. If you experience any of these symptoms, stop taking JAMP Solifenacin Succinate and see your doctor immediately.

INTERACTIONS WITH THIS MEDICATION

Before and while taking JAMP Solifenacin Succinate you should tell your doctor about your other medications, even the medicine you bought without prescription including vitamins and herbal supplements.

Solifenacin succinate is known to have drug interactions with the following drugs: Drugs known to prolong the QT/QTc interval and/or cause torsade de pointes, drugs that decrease electrolyte levels, anticholinergic drugs, drugs that stimulate the motility of the gut such as metoclopramide, ketoconazole, clarithromycin, erythromycin, diclofenac, nefazodone, verapamil.

Drinking grapefruit juice with JAMP Solifenacin Succinate may increase your blood level of solifenacin.

PROPER USE OF THIS MEDICATION

Usual Dose:

5 mg daily. The daily dose may be increased to 10 mg following consultation with your doctor. Swallow the tablet whole with water.

JAMP Solifenacin Succinate tablets can be taken with or without food.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If a dose is missed, the next tablet should be taken as planned. Doses should not be doubled to make up for a missed dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The following side effects have been reported in clinical trials with solifenacin succinate:

Most common side effects: dry mouth and constipation Common side effects: dry eyes, urinary retention, blurred vision, nausea, abdominal pain, indigestion, urinary tract infection.

The following side effects have been reported with the use of solifenacin succinate in worldwide post-marketing experience, although the frequency of events or a causal relationship with solifenacin succinate could not always be confirmed :

acid reflux, change in sense of taste, decreased appetite, delirium, dizziness, dry skin, fast or irregular heartbeat, feeling sleepy, glaucoma, hallucination, headache, high potassium levels, hypersensitivity reactions, intestinal blockage, itchiness, kidney ailment, liver problems, muscle weakness, nasal dryness, voice disorder, severe skin scaling and redness, itching (exfoliative dermatitis), severe skin rash, itchiness and fever (erythema multiforme), swelling in the lower limbs and vomiting.

Tell your doctor or pharmacist if you have any side effects while taking JAMP Solifenacin Succinate. This includes any side effects not listed above.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/effectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency medical attention
Only if severeIn all cases
RareAbdominal pain✓
Constipation for more than 3 days✓
Urinary retention✓
Very rareSwelling of the face or tongue, difficulty breathing✓
Fast or irregular heartbeat✓

Anaphylactic reactions

(severe allergic reactions)

✓

HOW TO STORE IT

Keep JAMP Solifenacin Succinate and all other medications out of the reach of children.

Store between 15oC – 30oC.

Do not keep medicine that is out of date or that you no longer need.

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction

    Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found at: www.jamppharma.com

Or by contacting JAMP Pharma Corporation at 1-866-399-9091.

JAMP Pharma Corporation

1310 rue Nobel

Boucherville, Quebec

J4B 5H3, Canada

Last Revised: December 6, 2021

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02428911

Revision date stated in the text: December 6, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Jamp Solifenacin Succinate

Rx or OTC
Prescription (Rx)?
DIN 02428911, 02428938
Schedule(s) PRESCRIPTION
Active ingredient(s) Solifenacin succinate
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BD Drugs for urinary frequency and incontinence
          1. G04BD08 Solifenacin
Company JAMP PHARMA CORPORATION
Current status Marketed
Current status date January 25, 2024
Strengths and forms
DIN Strength Dosage form(s) Current status
02428911 5 MG Tablet Marketed January 25, 2024
02428938 10 MG Tablet Marketed January 25, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.